WAYLAND, Mass.--(BUSINESS WIRE)--Candela Corporation (NASDAQ: CLZR) announced today that Health Canada has cleared the new QuadraLASE™ advanced CO2 fractional laser for distribution in Canada. Launched at the American Academy of Dermatology Annual Meeting in March 2009, the QuadraLASE is changing the way practitioners are looking at fractional CO2 laser treatments. With a unique combination of the proven performance of a CO2 laser and an innovative scanning device, the QuadraLASE is an effective solution for popular aesthetic treatments such as skin rejuvenation*, skin tightening/wrinkle reduction**, uneven tone and texture, and acne scarring.
